Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHARLES BIRBARA

NPI
1093705410
CMS profile
321368
Location
WORCESTER, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,896.48

121 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,819.49 120
Education $76.99 1

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 121 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHARLES BIRBARA

NPI 1093705410 · CMS profile ID 321368

WORCESTER, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 121 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1093705410?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHARLES BIRBARA, NPI 1093705410, CMS profile ID 321368. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 121 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1093705410?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). CHARLES BIRBARA, NPI 1093705410, CMS profile ID 321368. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 121 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1093705410?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
CHARLES BIRBARA, NPI 1093705410, CMS profile ID 321368, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 121 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1093705410?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

121 matching records · $2,896.48 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 121 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 121.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Aurinia Pharma U.S., Inc. $13.8308/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249412015 CMS
Novartis Pharmaceuticals Corporation $18.0007/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200137855 CMS
AstraZeneca Pharmaceuticals LP $20.3007/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214796166 CMS
Amgen Inc. $21.9707/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228465597 CMS
UCB, Inc. $39.1507/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224760718 CMS
GlaxoSmithKline, LLC. $27.0407/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191646703 CMS
ABBVIE INC. $23.0407/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201521078 CMS
UCB, Inc. $3.8007/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224760716 CMS
ABBVIE INC. $8.7707/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201521076 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.3606/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223056030 CMS
Amgen Inc. $17.4506/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228465603 CMS
ABBVIE INC. $31.0606/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201521074 CMS
UCB, Inc. $40.8606/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224760714 CMS
GlaxoSmithKline, LLC. $26.8106/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190704512 CMS
Amgen Inc. $18.7906/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228465613 CMS
ABBVIE INC. $11.7406/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201521072 CMS
Amgen Inc. $17.9906/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228465623 CMS
PFIZER INC. $29.3006/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230513518 CMS
Sandoz Inc. $23.5306/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181969449 CMS
ABBVIE INC. $9.0705/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201521070 CMS
AstraZeneca Pharmaceuticals LP $18.6105/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214785080 CMS
E.R. Squibb & Sons, L.L.C. $18.7705/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184814963 CMS
E.R. Squibb & Sons, L.L.C. $2.4405/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184814965 CMS
UCB, Inc. $47.1705/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224760712 CMS
Amgen Inc. $17.0205/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228465599 CMS
GlaxoSmithKline, LLC. $27.0405/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190616526 CMS
Amgen Inc. $19.2705/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228465625 CMS
PFIZER INC. $28.6205/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230518466 CMS
AstraZeneca Pharmaceuticals LP $18.3905/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214786562 CMS
Amgen Inc. $13.2504/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227064123 CMS
Novartis Pharmaceuticals Corporation $29.3504/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200137847 CMS
Amgen Inc. $6.5804/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227064127 CMS
E.R. Squibb & Sons, L.L.C. $24.8904/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184814949 CMS
ABBVIE INC. $11.9604/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201521068 CMS
Amgen Inc. $23.8904/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228465607 CMS
GlaxoSmithKline, LLC. $25.0504/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190446949 CMS
Aurinia Pharma U.S., Inc. $18.2304/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249423502 CMS
PFIZER INC. $28.6204/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230517733 CMS
AstraZeneca Pharmaceuticals LP $22.2404/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214785160 CMS
Sandoz Inc. $20.6904/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181969445 CMS
ABBVIE INC. $33.8904/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201521066 CMS
Amgen Inc. $19.2804/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228465619 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.2403/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223056028 CMS
Novartis Pharmaceuticals Corporation $23.9103/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200137845 CMS
Amgen Inc. $15.2903/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228465609 CMS
Amgen Inc. $23.1903/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228465621 CMS
PFIZER INC. $28.6203/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230514423 CMS
GlaxoSmithKline, LLC. $27.6203/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190822230 CMS
E.R. Squibb & Sons, L.L.C. $30.9103/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184814915 CMS
ABBVIE INC. $7.3702/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201521062 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,859.75 181
PY2020 $3,780.29 113
PY2021 $2,486.82 100
PY2022 $3,239.05 140
PY2023 $3,852.57 161
PY2024 $3,522.23 124
PY2025 $2,896.48 121

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $30,591.60 11
PY2024 Principal investigator $55,381.20 15
PY2023 Principal investigator $74,569.98 31
PY2022 Principal investigator $293,821.55 49
PY2021 Principal investigator $512,334.82 105
PY2020 Principal investigator $513,859.64 112
PY2019 Recipient $2,925.00 1
PY2019 Principal investigator $808,469.86 79

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,843.40 11/04/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202520189
Principal investigator 1 ABBVIE INC. $2,926.20 10/09/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202514665
Principal investigator 1 ABBVIE INC. $1,567.40 09/03/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202507889
Principal investigator 1 ABBVIE INC. $2,030.00 08/05/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202501798
Principal investigator 1 ABBVIE INC. $3,917.40 07/02/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202494665
Principal investigator 1 ABBVIE INC. $6,390.60 06/03/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202488849
Principal investigator 1 ABBVIE INC. $1,367.00 05/06/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202481111
Principal investigator 1 ABBVIE INC. $1,622.60 04/03/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202470016
Principal investigator 1 ABBVIE INC. $4,934.00 03/06/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
M15-998 - A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202456292
Principal investigator 1 ABBVIE INC. $1,190.60 02/05/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
M15-998 - A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202443893
Principal investigator 1 ABBVIE INC. $2,802.40 01/02/2025 Non-covered Recipient Entity
CLINICAL PHARMACOLOGY STUDY GROUP
M15-998 - A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202433401